<DOC>
	<DOCNO>NCT02213757</DOCNO>
	<brief_summary>The purpose study determine vaginal estrogen use associate resolution blood urine ( microscopic hematuria ) postmenopausal woman . The hypothesis postmenopausal woman blood urine ( microscopic hematuria ) high rate resolution hematuria treatment course vaginal conjugated equine estrogen cream compare placebo cream</brief_summary>
	<brief_title>Effect Vaginal Estrogen Asymptomatic Microhematuria ( AMH )</brief_title>
	<detailed_description>This randomize controlled trial vaginal estrogen cream postmenopausal woman microscopic hematuria ( AMH ) . Potential subject screen dipstick urinalysis catheterize urine specimen , follow microscopic urinalysis urine culture urine dipstick positive trace blood great . Women identify asymptomatic microscopic hematuria ( &gt; 3 red blood cell ( RBC ) per high power field ( hpf ) ) single urine microscopy specimen absence urinary tract infection benign cause eligible enrollment . Women meet inclusion criterion randomize either conjugate equine estrogen cream ( Premarin , 0.625mg conjugate estrogen ) placebo cream 8 week . Microscopic urinalysis catheterize urine specimen re-checked 8 week check reduction , resolution persistence AMH . During 8 week vaginal estrogen placebo , woman complete recommend AMH workup dictate American Urologic Association ( AUA ) guideline ( cystourethroscopy , serum blood urea nitrogen creatinine level , compute tomography ( CT ) scan abdomen pelvis without intravenous contrast ) .1 Validated questionnaire assess vaginal atrophy symptom urinary urgency frequency complete time randomization 8 week . Cost analysis standard AMH workup ( cystourethroscopy CT scan ) versus empiric treatment 8 week vaginal estrogen cream calculate base Medicare reimbursement , well market price vaginal estrogen cream Additionally , patient ask complete questionnaire ass level bother associate complete current AMH workup CT scan cystoscopy compare complete treatment course vaginal estrogen cream . Secondary analysis determine whether additional benefit trial period vaginal estrogen cream postmenopausal woman AMH prior reflexively screen urinary tract abnormality . We compare cost standard AMH workup treatment course vaginal estrogen cream , determine whether vaginal estrogen potential resolution AMH associate saving prior pursue workup . Additionally , questionnaire ask study participant whether would prefer undergo current AUA AMH workup treatment course vaginal cream , order ass bother anxiety associate intervention .</detailed_description>
	<mesh_term>Hematuria</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Postmenopausal woman Asymptomatic microscopic hematuria ( three red blood cell per high power field single urine microscopy ) absence urinary tract infection . Known urologic disease Presence gross hematuria Presence indwell urologic foreign body ( foley catheter , ureteral stent ) Inability obtain intravenous contrast CT scan ( elevated creatinine , severe contrast allergy ) History pelvic irradiation malignancy Not candidate vaginal estrogen Allergy vaginal estrogen Current prior diagnosis breast endometrial cancer History deep vein thrombosis/pulmonary embolus Hypercoagulable state</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Hematuria</keyword>
	<keyword>Menopause</keyword>
	<keyword>Urinalysis</keyword>
</DOC>